ClinicalTrials.gov
public full text
Public Domain
A Study to Evaluate the Efficacy and Safety of HBM9161 on Moderate to Severe Thyroid Eye Disease
Primary Objective: To preliminarily evaluate the efficacy of the treatment regimen of HBM9161 680 mg administered subcutaneously weekly and sequentially every other week for 12 weeks in Chinese patients with active moderate to severe TED.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- TSI and Its Relationship With Graves' Disease Relapse#813951
- In Vivo CAR-T for Refractory Graves' Disease#810410
- Safety and Pharmacology Study of SNX-5422 in Subjects With Refractory Solid Tumor Malignancies#825208
- RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma#912674
- A Non-interventional Cohort Safety Study of Patients With hATTR-PN#966816
Record · ID 992304
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive